FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention describes antagonist of nociceptine comprising amide derivative and its pharmaceutically acceptable salts of the formula [1] where R1 and R2 are similar or different and each is hydrogen atom, lower alkyl optionally substituted with hydroxy-group, amino-group, lower alkyl- -amino-group or di-(lower)-alkylamino-group; R3, R4 mean hydrogen atom; ring A is quinolyl, 5,6,7,8-tetrahydroacridinyl, 2,3-dihydro-1H-cyclopenta[b] quinolyl; ring B is phenyl, thienyl, furyl, pyrrolyl, pyrrolidinyl or oxazolyl; X means group of the formula: where E is single linkage or -O-; ring G is phenyl, naphthyl, benzofuranyl, 2,3-dihydrobenzofuranyl, cyclohexyl or 5,6,7,8-tetrahydro-2- naphthyl; R5 has different values; t = 0 or from 1 to 5; m = 0 or 1-8; n = 0 or 1-4. Invention describes also derivatives of amide of the formula [1'] and [1''] and also analgetic agent based on compounds of the formula [1'] and [1''], method of initiation of antagonistic effect to nociceptine including administration of compound of the formula [1], method of pain treatment including administration of compound of the formula [1'] or [1''] and pharmaceutical compositions containing compounds of the formula [1], [1'] or [1'']. Owing to antagonistic effect to nociceptine compounds show analgetic effect against acute pain. EFFECT: improved method of treatment, valuable medicinal properties of compounds. 14 cl, 48 tbl, 133 ex
Title |
Year |
Author |
Number |
METHOD OF RESIDUAL LIPOPROTEINS PRODUCING INHIBITION |
2004 |
- Okamoto Khirosi
- Furukava Noboru
- Sasase Tomokhiko
|
RU2330682C2 |
METHOD OF SYNTHESIS OF ISOXAZOLIDINEDIONE COMPOUND, METHOD OF SYNTHESIS OF OXAZOLYLETHANOL COMPOUND (VARIANTS), METHOD OF SYNTHESIS OF ASPARTATE COMPOUND, METHOD OF SYNTHESIS OF OXAZOLYLACETATE COMPOUND, METHOD OF SYNTHESIS OF METHANESULFONATE COMPOUND, METHOD OF SYNTHESIS OF BENZYLIDENE COMPOUND |
1999 |
- Ando Kodzi
- Suzuki Masanobu
|
RU2180663C2 |
THERAPEUTIC AGENT FOR TREATMENT OF DIABETIC PATIENTS |
1997 |
- Sinkai Khisasi
- Ozeki Khidekazu
- Furukava Noboru
|
RU2174114C2 |
SOLID COMPOSITION WITH IMPROVED SOLUBILITY AND STABILITY AND METHOD OF OBTAINING IT |
2005 |
- Jamane Sogo
- Jamane Khirofumi
- Sunami Masaki
|
RU2375046C2 |
AMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITION ELICITING INHIBITORY EFFECT ON XA FACTOR |
1999 |
- Katokh Susumu
- Ekota Katsujuki
- Khajasi Mikio
|
RU2201927C2 |
DERIVATIVES OF PROPIONIC ACID AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
1997 |
- Sinkai Khisasi
- Sibata Tsutomu
- Okhrui Satosi
|
RU2174121C2 |
INHIBITOR OF ACTIVITY OF CHOLESTEROL ESTERIFIED TRANSPORT PROTEIN, PROPHYLACTIC OR THERAPEUTIC AGENT, DERIVATIVES OF BIS-(2-AMIDOPHENYL)-DISULFIDE OR AMIDOTHIOPHENOL |
1998 |
- Sinkai Khisasi
- Maeda Kimija
- Okamoto Khirosi
|
RU2188631C2 |
NOVEL DERIVATIVES OF AZOLIDINEDIONE, METHOD OF THEIR SYNTHESIS (VARIANTS), PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF, METHOD OF PROPHYLAXIS OR TREATMENT, METHOD OF GLUCOSE LEVEL DECREASE AND INTERMEDIATE COMPOUND |
1997 |
- Lorej Vidia Bkhushan
- Lorej Bradzh Bkhushan
- Paraselli Rao Bkheema
- Gurram Ranga Madkhavan
- Ramanudzham Radzhagopalan
- Chakrabarti Randzhan
- Pakala Sarma K.S.
|
RU2200161C2 |
METHOD OF SYNTHESIS OF OXAZOLE COMPOUND |
1999 |
- Matsuda Kodzi
- Khara Katsuesi
- Akamatsu Minoru
|
RU2194042C1 |
RING-CONDENSED COMPOUNDS AND THEIR USING AS MEDICINAL AGENTS |
2000 |
- Khasimoto Khiromasa
- Mizutani Kendzi
- Esida Atsukhito
|
RU2223761C2 |